Risk of Chronic Kidney Disease in Bronchial Asthma

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age2-18
SponsorSohag University

About this trial

the study aims to determine the frequency and factors associated with chronic kidney disease among asthmatic patients in order to determine persons who are at risk of developing chronic kidney disease and require strict follow up in long run , to evaluate severity of asthma as a potential risk for developing kidney injury , to evaluate relationship between different inflammatory markers with severity of asthma and risk of deneloping chronic kidney disease

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

all children diagnosed as bronchial asthma at sohag university hospitals from age of 2 years to age of 18 years and donot have any associated disease

Disqualifiers

persons who have any chronic illness persons who have any associated disease with bronchial asthma persons who missing clinical and laboratory investigations persons who refusing to give written informed consent for the study

Trial population

cases (asthmatics) and control ( healthy ) from age of 2 years to 18 years

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

  • CBC, CRP ,ESR, ABG , interleukin 6, tumor necrotic factor alpha

    Diagnostic test

    compare results of investigations in asthmatics and non asthmatics

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: cases ( asthmatic patients)1 intervention
Group B: control (healthy persons)1 intervention

Trial outcomes

Primary outcomes

1

change in kidney function in asthmatics

change in serum creatinine , GFR calculation

Time frame
change in kidney function in asthmatics after diagnosis and start treatment through out the duration of study (an average 1 year )

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.